Company: AZN
Filing Date: 2025-09-29
Form Type: 6-K
Source: 0001104659-25-094039
Chunk: 15

Company: ASTRAZENECA PLC
Filing Date: 2025-09-29
Form: 6-K
Chunk 15
---
 entitlements settled within Euroclear Sweden in the same manner as they currently do.

Further details are set out in paragraph 2(b) ( DTC Eligible Swedish Listed Shares ) of Part III ( Settlement and Dealings in AstraZeneca Shares following the Settlement System Migration ) of this document.

<div align='center'>11</div>

**TABLE OF CONTENTS

Repositioning of interests in AstraZeneca Shares following the Effective Time**

Holders of AstraZeneca Shares (including AstraZeneca Shares represented by AstraZeneca DIs) will be entitled to reposition their holdings following the Effective Time, enabling them to trade their AstraZeneca Shares via the NYSE, the London Stock Exchange or Nasdaq Stockholm. The mechanism for doing so will depend on how such interest is held at the relevant time. Further details are set out in Part III ( Settlement and Dealings in AstraZeneca Shares following the Settlement System Migration ) of this document.

#### Trading currency
Following the Effective Time, AstraZeneca Shares will continue to trade in pounds sterling on the London Stock Exchange and in Swedish krona on Nasdaq Stockholm, and will trade in US dollars on the NYSE.

#### Mandates and elections
To the extent possible, all mandates, preferences, elections and instructions as to the payment currency of dividends, notices and other communications in force and duly notified to AstraZeneca immediately prior to the Effective Time relating to AstraZeneca Shares shall, unless and until revoked or amended, be deemed as (and continue to be) valid and remain unchanged following the Effective Time for DTC Eligible Uncertificated Shareholders, CSN Eligible Certificated Shareholders and CSN Participants. CSN Non-Eligible Certificated Shareholders or holders of Other ADS Shares who elect to hold their AstraZeneca Shares in certificated form or who fail to make an election within the Holding Period are expected to be required to submit revised payment preferences in respect of future mandates, preferences elections and instructions as to the payment currency of dividends.

#### 3.

#### Resolution to be proposed at the General Meeting
Shareholders should read the Notice of Meeting set out in Part VII ( Notice of General Meeting ) of this document for the full text of the Resolution and for further details about the General Meeting.

The Resolution is required to adopt the New Articles which will effect the Settlement System Migration, reflecting the operational changes resulting from such transfer and enabling Shareholders to hold, and settle transfers of